Lataa...
Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade
BACKGROUND: Although advanced-stage cervical cancer can benefit from current treatments, approximately 30% patients may fail after definitive treatment eventually. Therefore, exploring alternative molecular therapeutic approaches is imperatively needed for this disease. We have recently shown that a...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3702529/ https://ncbi.nlm.nih.gov/pubmed/23819460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-327 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|